<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6789623/results/search/test_trace/results.xml">
  <result pre="study suggests LiCl and DG as new drugs for the" exact="treatment" post="of PDCoV infection. PDCoV lithium chloride diammonium glycyrrhizinate apoptosis"/>
  <result pre="of interspecies transmission [5,6]. Cross-species transmission, facilitated by the widespread" exact="prevalence" post="of CoV in mammals and birds, and genetic diversity,"/>
  <result pre="porcine aminopeptidase N (APN) rendered non-susceptible cells susceptible to PDCoV" exact="infection" post="and greatly enhance PDCoV infection in HeLa cells [11]."/>
  <result pre="non-susceptible cells susceptible to PDCoV infection and greatly enhance PDCoV" exact="infection" post="in HeLa cells [11]. This suggests that PDCoV has"/>
  <result pre="HAAs is their broad-spectrum antiviral activity, which allows for immediate" exact="treatment" post="without a lead time being required to develop a"/>
  <result pre="functions in existing clinical drugs is often used in the" exact="screening" post="of modern emergency therapies. Traditional broad-spectrum antiviral drugs have"/>
  <result pre="not been researched. Therefore, we explored whether LiCl could inhibit" exact="infection" post="by PDCoV. The licorice extract isolated from the rhizome"/>
  <result pre="PRV [27]. According to previous studies, DG pre-treatement inhibited PRV" exact="infection" post="in a dose-dependent manner and reduced apoptosis [27]. Glycyrrhizin"/>
  <result pre="and Figure 3B). In IFA, the fluorescence intensity declined after" exact="treatment" post="with 10–60 mM LiCl or 125–1250 μg/mL DG in"/>
  <result pre="mean relative viral mRNA levels. In viral attachment assays, DG" exact="treatment" post="led to a significant reduction of viral mRNA levels"/>
  <result pre="for 2 h at room temperature or 37 °C before" exact="infection" post="of LLC-PK1 cells. The infectious titer was determined by"/>
  <result pre="experiments, the cells were infected with PDCoV [ multiplicity of" exact="infection" post="(MOI) = 0.05], and 60 mM LiCl or 1250"/>
  <result pre="6B). For DG, the latest effective time point of drug" exact="treatment" post="was 12 hpi (Figure 6C). Therefore, we can conclude"/>
  <result pre="PK1 cell apoptosis caused by PDCoV infection. 4. Discussion PDCoV" exact="infection" post="can cause vomiting and watery diarrhea in piglets and"/>
  <result pre="there are no records of clinically effective agents for the" exact="treatment" post="of PDCoV infection, and no compound has shown antiviral"/>
  <result pre="determine if DG can be used not only as a" exact="treatment" post="but also for preventing PDCoV infection. Because DG has"/>
  <result pre="and DG could inhibit LLC-PK1 cell apoptosis caused by PDCoV" exact="infection" post="similarly to the results of a previous report [28]."/>
  <result pre="appropriate dose or be given as an intramuscular drug for" exact="treatment" post="at the early onset of an epidemic. Further studies"/>
  <result pre="other CoVs and their mechanism of action to control PDCoV" exact="infection" post="in vivo. Author Contributions Conceived and designed the experiments:"/>
  <result pre="PathwayVirus Res.201825311212310.1016/j.virusres.2018.06.00829940190 Figure 1 Cytotoxic effect of LiCl and DG" exact="treatment" post="in LLC-PK1 cells. (A) Chemical structure of diammonium glycyrrhizinate"/>
  <result pre="incubated with PDCoV (MOI 0.05) for 1 h, followed by" exact="treatment" post="with 60 mM LiCl (B) or 1250 μg/mL DG"/>
 </snippets>
</snippetsTree>
